Related Experiment Videos
Design of beta-turn based therapeutic agents
K Suat Kee1, Seetharama D S Jois
1Department of Pharmacy, 18 Science drive 4, National University of Singapore, Singapore 117543.
Current Pharmaceutical Design
|May 29, 2003
Summary
Peptides are crucial for biological processes but have poor bioavailability. This review explores beta-turn mimetics, which mimic essential peptide structures to create more effective therapeutic agents.
Area of Science:
- Biochemistry
- Medicinal Chemistry
- Drug Discovery
Background:
- Peptides and proteins are vital for numerous biological functions.
- Receptor-ligand interactions frequently involve beta-turn structures.
- Poor bioavailability and pharmacokinetics limit peptide drug development.
Purpose of the Study:
- To highlight the significance of beta-turns in designing peptidomimetics.
- To review strategies for mimicking beta-turns.
- To discuss applications in developing potent peptide analogues.
Main Methods:
- Literature review of beta-turn mimicking strategies.
- Analysis of peptidomimetic design principles.
- Case studies on disease applications.
Main Results:
- Beta-turn structures are critical for peptide-receptor interactions.
- Peptidomimetics offer improved bioavailability and pharmacokinetics.
- Mimicking beta-turns enhances rigidity and optimizes receptor binding.
Conclusions:
- Beta-turn mimetics represent a promising approach for therapeutic drug design.
- Rigidified peptidomimetics can lead to more effective drug candidates.
- Further research into beta-turn mimicking strategies can advance drug discovery.